Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Janssen BioPharma, Inc.
- Target Recruit Count
- 130
- Registration Number
- NCT03403348
- Locations
- 🇬🇧
hVIVO Services Limited, London, United Kingdom
🇬🇧Hammersmith Medicines Research Ltd, London, United Kingdom
News
No news found